GlaxoSmithKline PLC 50mcg P/S Beconase Aqueous Nasal Spray 200metered sprays

The barcode 5000124430504 corresponds to the GlaxoSmithKline PLC product "Beconase Aqueous Nasal Spray 50mcg/200mL". This is a prescription-only, over-the-counter (OTC) medication used to treat nasal congestion associated with allergies.

Beconase Aqueous Nasal Spray contains azelastine hydrochloride, an antihistamine that helps relieve nasal congestion by reducing swelling in the nasal passages. The spray is administered directly into the nostrils using a metered dose inhaler (MDI).

The product has a warning label regarding the potential for allergic reactions, including skin rashes, itching, and difficulty breathing. It's also important to note that Beconase Aqueous Nasal Spray should not be used in people with a history of severe allergic reactions or asthma.

As for prices, they vary depending on the country, pharmacy, and availability. In the United States, a 30-day supply typically costs between $20-$50. In the UK, where GlaxoSmithKline is based, the product is available by prescription only, but prices range from around £10-£30 (approximately $13-$40 USD) for a single dose.

It's worth noting that Beconase Aqueous Nasal Spray has not been associated with any major safety concerns or issues related to its active ingredient. However, as with any medication, it's essential to use the product as directed and follow the recommended dosage to minimize potential side effects.

In terms of health-related disclaimers, since this is a consumable product, there are standard warnings and cautions listed on the label. These include:

• Do not take Beconase Aqueous Nasal Spray if you have a history of severe allergic reactions or asthma.
• Use with caution in patients with nasal polyps, high blood pressure, or heart disease.
• Avoid using Beconase Aqueous Nasal Spray if you are pregnant or breastfeeding.

These warnings are intended to inform patients and healthcare professionals about the potential risks and benefits associated with the product.